Skip to content

Mobile Phone Intervention for Increasing Adherence to Treatment for Type 2 Diabetes in an Urban Area of Bangladesh: A Randomized Controlled Trial

Mobile Phone Intervention for Increasing Adherence to Treatment for Type 2 Diabetes in an Urban Area of Bangladesh: A Randomized Controlled Trial - MPID

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00005188
Enrollment
216
Registered
2013-08-05
Start date
2013-09-08
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DIABETES E11

Interventions

Group 1: In the Intervention are, the study participants will receive one SMS per day for 6 months. The SMS will include medication reminder, clinic attendance, health education and life style related

Sponsors

ICDDR, B
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: • Diagnosed as Type2 diabetic patient according to WHO criteria • Currently on oral medication therapy and able to afford cost for 6 months treatment • Patients with a personal mobile phone • Patients who know how to retrieve/read SMS on mobile phone (Bangla with English alphabets) • Willingness to receive SMS for 6 months at least one SMS per day • Patient registered with the health centre and lives in Dhaka city • Provide written informed consent and agree for a follow up visit after 6 months. (SMS reminders will be sent for the follow up visit).

Exclusion criteria

Exclusion criteria: • Patients whose clinical condition might have interfered with the study such as uncontrolled diabetes, mental illness, other serious illness or co-morbidities • Patients unable to give their informed consent or agree for follow up visit. • Patients who do not own a mobile phone or cannot read SMS messages • Patients who reside outside Dhaka city

Design outcomes

Primary

MeasureTime frame
Primary outcome measurements will be performed after 6 months of intervention, as follows: •Changes in HbA1c (Compare HbA1C at baseline and after 6 months)

Secondary

MeasureTime frame
Secondary outcome measurements will be performed after 6 months as follows: • Self-reported medication adherence (measured by Morisky-8 Medication Adherence Questionnaire) • Clinic attendance (Self-reported questionnaires and hospital records) • Quality of Life (EQ-5D Questionnaires) • Cost effectiveness of SMS interventions in reducing HbA1c (Questionnaires)

Countries

Bangladesh

Contacts

Public ContactShariful Islam

LMU/ ICDDR, B

shariful.islam@icddrb.org+8801939366930

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 7, 2026